Last reviewed · How we verify
Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis
The purpose of this study is to determine whether the use of EGb 761 by patients with Relapsing-Remitting Multiple Sclerosis is effective in improving cognition, when compared to placebo.
Details
| Lead sponsor | Ipsen |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 47 |
| Start date | Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Interventions
- EGb 761® (Tanakan®)
Countries
France